|

Ganitumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AMG 479, Anti-IGF-1R Human Monoclonal Antibody AMG-479

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Recurrent Sarcoma1
  • Resectable Sarcoma1
  • Metastatic Sarcoma1
  • Cancer1

Houston, Texas1 trial

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

M D Anderson Cancer Center

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.